685TiP A phase I, multicenter trial (“KinLET”) of [177Lu]Lu-edotreotide for treatment of somatostatin receptor positive solid tumors or lymphoma, in patients two to less than 18 years of age

Autor: Mata Fernandez, M.C., Cohen, K.J., Melnyk, S., Rotger, A., Thevenet, T.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S532-S532
Databáze: ScienceDirect